GreenLight Biosciences Holdings, PBC Warrant
GRNAW
GRNAW was delisted on the 21st of July, 2023.
27 hedge funds and large institutions have $15.5M invested in GreenLight Biosciences Holdings, PBC Warrant in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 9 closing their positions.
67% more capital invested
Capital invested by funds: $9.25M → $15.5M (+$6.24M)
13% less funds holding
Funds holding: 31 → 27 (-4)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$693K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$120K |
| 3 |
Walleye Capital
New York
|
+$39.2K |
| 4 |
HF
HRT Financial
New York
|
+$22.1K |
| 5 |
Walleye Trading
New York
|
+$21.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$640K |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$386K |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$365K |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$300K |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$268K |
GRNAW Hedge Fund Activity: Q1 2022 in Review
27 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Warrant (GRNAW) for Q1 2022, worth a combined $15.5M — up 67% from $9.25M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of GRNAW and 5 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 4 added.
The largest buyer was LMR Partners, adding an estimated $693K. The largest seller was AQR Arbitrage, exiting entirely with an estimated $640K sold.
- 27 institutional investors held GreenLight Biosciences Holdings, PBC Warrant (GRNAW) as of Q1 2022, down from 31 in Q4 2021.
- Funds reported $15.5M of GreenLight Biosciences Holdings, PBC Warrant stock for Q1 2022, up 67% quarter-over-quarter.
- 5 funds opened new GreenLight Biosciences Holdings, PBC Warrant positions in Q1 2022 and 9 closed out, a net change of -4 holders.
- The largest GreenLight Biosciences Holdings, PBC Warrant buyer in Q1 2022 was LMR Partners, an estimated $693K added.
- The largest GreenLight Biosciences Holdings, PBC Warrant seller in Q1 2022 was AQR Arbitrage, an estimated $640K sold.
Based on aggregated 13F filings for Q1 2022.